000			nab a22 7a 4500
999			_c16177 _d16177
003			PC16177
005			20210406103455.0
008			210111b xxu||||| |||| 00| 0 eng d
040			_cH12O
041			_aspa
100			_91488 _aPraga Terente, Manuel _eNefrología
245	0	0	_aResumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por VIH. _h[artículo de revisión]
260			_bNefrología : publicación oficial de la Sociedad Española Nefrologia, _c2014
300			_a34(6):768-88.
500			_aFormato Vancouver: Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G et al. Resumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por VIH. Nefrologia. 2014 Nov 17;34(6):768-88.
501			_aPMID: 25415577
504			_aContiene 3 referencias
520			_aThe aim of this article is to update the 2010 recommendations on the evaluation and management of renal disease in HIV-infected patients. Renal function should be monitored in all HIV-infected patients. The basic renal work-up should include measurements of serum creatinine, estimated glomerular filtration rate by CKD-EPI, urine protein-to-creatinine ratio, and urinary sediment. Tubular function tests should include determination of serum phosphate levels and urine dipstick for glucosuria. In the absence of abnormal values, renal screening should be performed annually. In patients treated with tenofovir or with risk factors for chronic kidney disease (CKD), more frequent renal screening is recommended. In order to prevent disease progression, potentially nephrotoxic antiretroviral drugs are not recommended in patients with CKD or risk factors for CKD. The document provides indications for renal biopsy and advises on the optimal time for referral of a patient to the nephrologist. The indications for and evaluation and management of dialysis and renal transplantation are also addressed.
710			_986 _aServicio de Nefrología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc16177.pdf _ySolicitar documento
942			_2ddc _cREV _n0